+
MAN Industries to Raise Rs 3 Billion Via Equity and Warrants
ECONOMY & POLICY

MAN Industries to Raise Rs 3 Billion Via Equity and Warrants

MAN Industries (India) Ltd. has announced that its Board of Directors has approved a capital raise of up to Rs 3 billion through a preferential allotment of equity shares and convertible warrants. The move, subject to shareholder and regulatory approvals, aims to fund the company’s expansion projects and strengthen its balance sheet.

The proposed allotment includes the issuance of 1.22 million convertible warrants to promoter group entity Man Finance Private Limited at Rs 328 each (inclusive of a Rs 323 premium), aggregating to approximately Rs 400 million. Each warrant will be convertible into one equity share within 18 months of allotment.

The funds raised will be deployed to meet ongoing capital expenditure for the company’s manufacturing expansions in Jammu and Saudi Arabia, address working capital needs, and support long-term strategic initiatives.

An Extraordinary General Meeting (EGM) will be held virtually on 25 June 2025 to seek shareholder approval for the proposal.
Managing Director Nikhil Mansukhani commented, “The capital infusion is a strategic move that will strengthen our execution capabilities, bolster growth momentum, and enhance long-term shareholder value.”

MAN Industries (India) Ltd. has announced that its Board of Directors has approved a capital raise of up to Rs 3 billion through a preferential allotment of equity shares and convertible warrants. The move, subject to shareholder and regulatory approvals, aims to fund the company’s expansion projects and strengthen its balance sheet.The proposed allotment includes the issuance of 1.22 million convertible warrants to promoter group entity Man Finance Private Limited at Rs 328 each (inclusive of a Rs 323 premium), aggregating to approximately Rs 400 million. Each warrant will be convertible into one equity share within 18 months of allotment.The funds raised will be deployed to meet ongoing capital expenditure for the company’s manufacturing expansions in Jammu and Saudi Arabia, address working capital needs, and support long-term strategic initiatives.An Extraordinary General Meeting (EGM) will be held virtually on 25 June 2025 to seek shareholder approval for the proposal.Managing Director Nikhil Mansukhani commented, “The capital infusion is a strategic move that will strengthen our execution capabilities, bolster growth momentum, and enhance long-term shareholder value.”

Next Story
Infrastructure Transport

Syama Prasad Mookerjee Port Partners to Redevelop Nimtala Ghat

Kolkata: Syama Prasad Mookerjee Port, Kolkata (SMPK), signed a Memorandum of Understanding (MoU) on Tuesday with PS Group Realty Private Limited to redevelop and beautify Nimtala Ghat as part of PS Group’s Corporate Social Responsibility (CSR) initiative.The agreement was formalised at SMPK’s Head Office at 15, Strand Road, in the presence of SMPK chairman Rathendra Raman, deputy chairman Samrat Rahi, PS Group directors Saurav Dugar, Gaurav Dugar, Arun Sancheti, and senior SMPK officials.Under the MoU, PS Group will undertake the full redevelopment and permitted construction of Nimtala Imm..

Next Story
Infrastructure Urban

CSIR-NCL and Covestro Collaborate to Upcycle Polyurethane Waste

In a move towards sustainable plastic waste management, Pune-based CSIR-National Chemical Laboratory (CSIR-NCL) signed a Memorandum of Understanding (MoU) with Covestro (India) Private Limited on Wednesday to develop innovative upcycling technologies for polyurethane waste.Polyurethane is notoriously difficult to recycle, with current methods often proving inefficient, costly, and environmentally harmful. This collaboration aims to address existing challenges, including high energy usage and deterioration of material quality during recycling.Ashish Lele, director of CSIR-NCL, stated, “This p..

Next Story
Infrastructure Urban

Torrent Pharma Seeks CCI Approval for Rs 195 Billion JB Chemicals Deal

Ahmedabad-based Torrent Pharmaceuticals has sought clearance from the Competition Commission of India (CCI) to acquire a majority stake in J B Chemicals and Pharmaceuticals in a Rs 195 billion deal.Upon completion, Torrent Pharmaceuticals will become India’s second most valuable pharmaceutical company.The move follows Torrent’s June announcement to acquire a majority stake in J B Chemicals for Rs 195 billion.“The proposed combination pertains to the acquisition of shareholding by Torrent Pharmaceuticals Ltd in J B Chemicals & Pharmaceuticals Ltd, followed by the merger of the target ..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Talk to us?